Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

RF Barth, MG H Vicente, OK Harling, WS Kiger… - Radiation …, 2012 - Springer
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

Boron neutron capture therapy for malignant brain tumors

SI Miyatake, S Kawabata, R Hiramatsu… - Neurologia medico …, 2016 - jstage.jst.go.jp
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis

T Nihashi, IJ Dahabreh… - American Journal of …, 2013 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Studies have assessed PET by using various tracers to
diagnose disease recurrence in patients with previously treated glioma; however, the …

The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles

N Nonoguchi, SI Miyatake, M Fukumoto… - Journal of neuro …, 2011 - Springer
The cell type and localization of vascular endothelial growth factor (VEGF)-producing cells in
human radiation necrosis (RN) are investigated from a histopathological and …

Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain

SI MIyatake, N NoNoguchI, M FuruSe… - Neurologia medico …, 2015 - jstage.jst.go.jp
New radiation modalities have made it possible to prolong the survival of individuals with
malignant brain tumors, but symptomatic radiation necrosis becomes a serious problem that …

The development of boron analysis and imaging in boron neutron capture therapy (BNCT)

Q Dai, QY Yang, X Bao, J Chen, M Han… - Molecular …, 2022 - ACS Publications
Boron neutron capture therapy (BNCT) is a selective biological targeted nuclide technique
for cancer therapy. It has the following attractive features: good targeting, high effectiveness …

Survival benefit of boron neutron capture therapy for recurrent malignant gliomas

SI Miyatake, S Kawabata, K Yokoyama… - Journal of neuro …, 2009 - Springer
We have applied boron neutron capture therapy (BNCT) to malignant brain tumors. Here we
evaluated the survival benefit of BNCT for recurrent malignant glioma (MG). Since 2002, we …

Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2–Radiological features and metric markers

C Le Fevre, JM Constans, I Chambrelant… - Critical reviews in …, 2021 - Elsevier
After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …

Radionecrosis after stereotactic radiotherapy for brain metastases

E Le Rhun, F Dhermain, G Vogin, N Reyns… - Expert review of …, 2016 - Taylor & Francis
Introduction: Radionecrosis (RN) represents the main complication of stereotactic
radiotherapy (SRT) for brain metastases. It may be observed in up to 34% of cases at 24 …

Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation

YW Park, D Choi, JE Park, SS Ahn, H Kim, JH Chang… - Scientific reports, 2021 - nature.com
The purpose of this study was to establish a high-performing radiomics strategy with
machine learning from conventional and diffusion MRI to differentiate recurrent glioblastoma …